Stay updated on Nivolumab in AML Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Prevention Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The Publications section now states that entries are automatically filled from PubMed, and a new revision tag (v3.3.2, 2025-11-19) replaces the previous note and revision (v3.2.0, 2025-10-24).
    Difference
    0.2%
    Check dated 2025-11-24T19:06:17.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Two new timestamp fields were added: Results First Posted (Estimated) and Last Update Posted (Estimated); these are metadata updates and do not alter substantive study content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:06:09.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a Results section detailing progression-free survival (PFS), overall survival (OS), non-relapse mortality (NRM), and adverse events, with Results First Posted dates and links to the Informed Consent Form and the Study Protocol / Statistical Analysis Plan.
    Difference
    1%
    Check dated 2025-11-10T16:24:30.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A 'Results Submitted' status has replaced the previous 'No Results Posted' indicator on the study page for REMAIN (NCT02275533). This shows that trial results have been submitted.
    Difference
    0.3%
    Check dated 2025-11-03T12:48:53.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page has added a
    Difference
    0.0%
    Check dated 2025-10-20T06:39:43.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Minor update: new dates and two labeled terms added; several old dates removed. Overall, no substantive changes to core content or pricing.
    Difference
    0.6%
    Check dated 2025-10-13T03:10:46.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.